GEN Exclusives

More »

About GEN


Genetic Engineering & Biotechnology News (GEN) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, like news and analysis as well as blogs, podcasts, webinars, polls, videos, and application notes. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Print and Online Focus

GEN's print coverage, which can easily be accessed online, includes industry-standard tutorials and technical articles in bioprocessing, assays, and drug discovery; feature articles on emerging technologies; product roundups and regional biofocus articles on biotech hotbeds; as well as reports from key scientific and industry meetings.

Our acclaimed columns include Wall Street BioBeat, Point of View, Corporate Profile, Biomarket Trends, Legal Affairs, Best of the Web, and Best Science Apps. Other regular, informative content includes New Product listings and the Calendar of Events column for bioscience and bioindustry meetings. GEN's print edition also features the following news columns: Clinical Trials, Genomics & Proteomics, Discovery and Development, Bioprocessing, Molecular Diagnostics, Inside Industry, Products & Services, and People in the News.

GEN online has additional editorial coverage including GEN News Highlights, which covers the most important stories in the life sciences on a daily basis, helping you stay current. The Insight & Intelligence™ section is an online exclusive column that slices and dices the latest news and trends that are shaping the industry. BioPerspectives is another online exclusive offering that discusses controversial, hot topics that are affecting biotech. Also, GEN's Expert Tips offer concise, straight-to-the point guidance on a range of topics to help you in your biotech research.

GEN online also provides you with illustrative and instructional Webinars, Videos and Application Notes on technology developments. You can also listen to thought-provoking Podcasts, hosted by GEN's editor in chief, John Sterling, and take part in our Polls, which are picked based on high-profile news events.

You can contact GEN by visiting this page. To advertise feel free to review our Editorial Calendar, Media Kit, and Editorial Guidelines.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?